不妊検査・不妊治療のヨーロッパ市場

◆英語タイトル:EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025
◆商品コード:INKW704102
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年4月1日
◆ページ数:86
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD1,950 ⇒換算¥214,500見積依頼/購入/質問フォーム
Multi LicenseUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、不妊検査・不妊治療のヨーロッパ市場について調査・分析し、不妊検査・不妊治療のヨーロッパ市場動向、市場予測、セグメント別分析、市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEY FINDINGS
Europe Infertility testing and treatment market generated a revenue of $5874 million in 2016 and is anticipated to contribute $9874 million by 2025, growing at a CAGR of 6.01%. Europe has the largest market share of In-vitro fertilization market. It pioneered the IVF technique and continuous research and development and investment has led to constant market growth. The global in-vitro fertilization market is poised to grow in 2017-2025 The various reasons for growth of the in-vitro fertilization market are increasing infertility across the world, delayed pregnancies, growing social acceptance of in-vitro fertilization, improving healthcare infrastructure and more awareness.
In-vitro fertilization refers to fertilization of egg with sperm outside the female body. It is a process the helps infertile couples have a child. WHO estimated that almost 25% couples in developing countries are infertile. There is a growing rate of infertility all over the globe. Reasons for infertility are increasing late marriages leading to higher maternal age, gynecological issues, growing incidences of obesity and addiction to alcohol, smoking and tobacco.

In-vitro fertilization market is segmented on the basis of geography, instruments, transfer techniques, procedure and end users. Various kinds of transfer techniques for IVF are fresh embryo transfer technique, frozen embryo transfer technique and donor egg transfer technique. IVF market is classified on the basis of IVF procedure and it can be either Intra cytoplasmic sperm injection (ICSI) or frozen embryo replacement (FER) or pre-implantation genetic diagnosis (PGD). IVF market is also classified on the basis of instruments used, which can be cryosystems, incubators, imaging systems, sperm separation systems, disposables and consumable ovum aspiration pump and others. End-users for IVF technology can be either hospitals or fertility clinics or surgical centers or clinical research institutes.

Market Insights
Market drivers for in-vitro fertilization are increasing rates of infertility all over the world, late pregnancies, social acceptance of in-vitro fertilization, growing awareness about this process, improving healthcare infrastructure and increase in healthcare expenditure.

Currently intra cytoplasmic sperm injection (ICSI) has the highest market share for IVF procedure and it is expected that it will continue to show good growth over the forecast period. Frozen embryo replacement (FER) will be the fastest growing segment during 2016-2022 due to higher success rates. FER has advantages like fewer miscarriages rate, increased implantation rate and low risk of pre-term labor.

Fresh non-donor embryo technique has the highest market share in the IVF market; IVF with ICSI is most widely used in case of fresh non-donor eggs followed by IVF without ICSI. Frozen non-donor market growth has the highest growth rate and will continue to have so in the forecast period. Fertility clinics are the largest end user accounting for 75% market share.

Factors that will restrain market growth are high costs associated with the procedure, low awareness in developing economies like Africa, ethical considerations and insufficient reimbursement policies for IVF treatment.

【レポートの目次】

1. RESEARCH SCOPE
1.1. SCOPE OF THE MARKET STUDY
1.2. WHO WILL FIND THIS REPORT USEFUL?
1.3. STUDY AND FORECASTING YEARS
1.4. SCOPE OF THE MARKET STUDY
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. INFERTILITY CAUSES & MARKEY DYNAMICS
3.2. MALE AND FEMALE INFERTILITY
4. DRIVERS AND IMPACT
5. RESTRAINS AND IMPACT
6. MARKET OPPORTUNITIES
7. MARKET CHALLENGE
8. MARKET SEGMENTATION
9. MALE INFERTILITY
9.1. MARKET BY MALE INFERTILITY TESTING
9.2. MALE INFERTILITY TREATMENT TYPES
10. FEMALE INTERTILITY
10.1. MARKET BY FEMALE INFERTILITY
10.2. HYSTEROSALPINGOGRAPHY
10.3. LAPAROSCOPY
10.4. TRANSVAGINAL ULTRASOUND
10.5. OVARIAN RESERVE TESTING
10.6. HORMONE TESTS
10.7. OTHERS (GENETIC TESTING)
11. FEMALE INFERTILITY TREATMENT TYPES
12. KEY ANALYTICAL
13. REGIONAL ANALYSIS
14. EUROPE
14.1. UK
14.2. GERMANY
14.3. FRANCE
14.4. 10.2.4 NORDICS
14.5. 10.2.5 RUSSIA
15. COMPETITIVE ANALYSIS
15.1. ANDROLOGY SOLUTIONS
15.2. FERRING PHARMACEUTICALS
15.3. HALOTECHDNA
15.4. MERCK SERONO
15.5. ORIGIO

LIST OF TABLES
1. EUROPE INFERTILITY TREATMENT MARKET BY GENDER 2017-2025($MILLION)
2. EUROPE AVERAGE COST COMPARISONS OF VARIOUS TREATMENTS
3. EUROPE MALE INFERTILITY TREATMENT MARKET IN $MILLION (2017-2025)
4. EUROPE MALE INFERTILITY TESTING MARKET IN $MILLION (2017-2025)
5. ADVANTAGES & DISADVANTAGES OF VARIOUS DNA SHEARING METHODS
6. EUROPE DNA FRAGMENTATION MARKET BY REGION, 2017-2025(IN $MILLION)
7. EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2017-2025(IN $MILLION)
8. EUROPE SPERM PENETRATION ASSAY MARKET BY REGION, 2017-2025(IN $MILLION)
9. EUROPE CASA MARKET, 2017-2025(IN $MILLION)
10. EUROPE SPERM AGGLUTINATION MARKET BY REGION, 2017-2025(IN $MILLION)
11. EUROPE MICROSCOPIC EXAMINATION MARKET BY REGION, 2017-2025(IN $MILLION)
12. EUROPE FEMALE INFERTILITY TESTING MARKET, 2017-2025(IN $MILLION)
13. EUROPE OVULATION TESTING MARKET BY REGION, 2017-2025(IN $MILLION)
14. EUROPE HYSTEROSALPINGOGRAPHY MARKET, 2017-2025(IN $MILLION)
15. EUROPE LAPAROSCOPY MARKET, 2017-2025(IN $MILLION)
16. EUROPE TRANSVAGINAL ULTRASOUND MARKET (2017 – 2025) (IN $ MILLION)
17. EUROPE MARKET FOR OVARIAN RESERVE TESTING, 2017-2025(IN $MILLION)
18. EUROPE IVF TREATMENT MARKET BY REGION, 2017-2025(IN $MILLION)
19. EUROPE IUI TREATMENT MARKET BY REGION, 2017-2025(IN $MILLION)
20. EUROPE DRUG AND HORMONE THERAPIES MARKET BY REGION, 2017-2025(IN $MILLION)
21. EUROPE INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)

LIST OF FIGURES
1. MARKET SHARES OF INFERTILITY TREATMENT SEGMENTS, 2016
2. CAUSES OF INFERTILITY BASED ON GENDER
3. MAJOR FERTILITY TREATMENT DESTINATION RANKING
4. NUMBER OF IVF CYCLES PERFORMED IN THE US
5. UK INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)
6. GERMANY INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)
7. FRANCE INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)
8. NORDICS INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)
9. RUSSIA INFERTILITY TREATMENT MARKET, 2017-2025(IN $MILLION)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不妊検査・不妊治療のヨーロッパ市場(EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆